Role of Phosphatidylinositol 3-Kinase and Its Catalytic Unit PIK3CA in Cervical Cancer: A Mini-Review

Role of Phosphatidylinositol 3-Kinase and Its Catalytic Unit PIK3CA in Cervical Cancer: A Mini-Review

In complicated disorders like cancer, signaling pathways form a tangled network. Targeting one gene may result in an unfavorable reaction from another off-target gene. Such entwined complexities may result in treatment resistance or failure in cancer patients. The PI3K/Akt/mTOR (phosphoinositol 3-ki...

Full description

Saved in:

Bibliographic Details
Main Authors:	Guojuan Sun, Qiang Zhang, Yi Liu, Ping Xie
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Applied Bionics and Biomechanics
Online Access:	http://dx.doi.org/10.1155/2022/6904769
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Retracted: Role of Phosphatidylinositol 3-Kinase and Its Catalytic Unit PIK3CA in Cervical Cancer: A Mini-Review
by: Applied Bionics and Biomechanics
Published: (2023-01-01)

The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer
by: Valentina Cutano, et al.
Published: (2025-04-01)

P479: PIK3CA-related overgrowth syndrome: To exome or not?
by: Moon Ley Tung, et al.
Published: (2025-01-01)

Oncogenic PIK3CA corrupts growth factor signaling specificity
by: Ralitsa R Madsen, et al.
Published: (2024-12-01)

Lessons learned from experience of phosphatidylinositol 3-kinase inhibitors in chronic lymphocytic leukemia and lymphoma
by: Paola Ghione, et al.
Published: (2025-07-01)

Dysfunctional mechanotransduction regulates the progression of PIK3CA-driven vascular malformations
by: Wen Yih Aw, et al.
Published: (2025-03-01)

Mutations of the PIK3CA gene in patients with breast cancer in the Krasnoyarsk region
by: A. V. Zyuzyukina, et al.
Published: (2024-07-01)

Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
by: Gizem Teoman, et al.
Published: (2024-12-01)

Phosphatidylinositol 3-kinase regulatory subunit 1 and phosphatase and tensin homolog as therapeutic targets in breast cancer
by: Ebubekir Dirican, et al.
Published: (2017-03-01)

Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis.
by: Peter Recknagel, et al.
Published: (2012-01-01)

Exploring the mutational spectrum of key kinase genes PIK3CA, BRAF, EGFR, ALK and ROS1 in oral squamous cell carcinoma
by: Fouzia Nawab, et al.
Published: (2025-08-01)

In silico prediction of the action of bromelain on PI3K/Akt signalling pathway to arrest nasopharyngeal cancer oncogenesis by targeting phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha protein
by: Alyaa Syafiqah Shamsuri, et al.
Published: (2024-11-01)

Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways to enhance chemoradiotherapy in locally advanced rectal cancer
by: Aoife Carr, et al.
Published: (2025-01-01)

Anaplasma phagocytophilum infection modulates expression of megakaryocyte cell cycle genes through phosphatidylinositol-3-kinase signaling.
by: Supreet Khanal, et al.
Published: (2017-01-01)

PIK3CA mutations in breast cancer with low HER2 / neu expression
by: I. A. Pavlenko, et al.
Published: (2022-12-01)

The role of PIK3CA mutations in the development of breast cancer (a literature review)
by: A. O. Pryvalova, et al.
Published: (2020-08-01)

Oncogenic activation of PIK3CA in cancers: Emerging targeted therapies in precision oncology
by: Yuxiang Wang, et al.
Published: (2025-03-01)

Vitamin D3 Activates Phosphatidylinositol-3-Kinase/Protein Kinase B via Insulin-Like Growth Factor-1 to Improve Testicular Function in Diabetic Rats
by: Yanyan He, et al.
Published: (2019-01-01)

Synergistic Inhibition of Colorectal Cancer Growth by Qingjie Fuzheng Granule and 5-Fluorouracil through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway
by: Jin-Yan Zhao, et al.
Published: (2025-04-01)

Pathologically Complete Response to Camrelizumab and Apatinib in Advanced Cervical Cancer with PTEN, PIK3CA, MTOR, and ARID1A Mutations: A Case Report
by: Zhi-Ping Liu, et al.
Published: (2025-03-01)

miR-29a Downregulates PIK3CA Expression and Inhibits Cervical Cancer Cell Dynamics: A Comparative Clinical Analysis
by: Hyorim Jeong, et al.
Published: (2024-11-01)

A humanized yeast-based toolkit for monitoring phosphatidylinositol 3-kinase activity at both single cell and population levels
by: Julia María Coronas-Serna, et al.
Published: (2018-11-01)

Investigation of the Roles of Phosphatidylinositol 4-Phosphate 5-Kinases 7,9 and Wall-Associated Kinases 1–3 in Responses to Indole-3-Carbinol and Biotic Stress in Arabidopsis Thaliana
by: Hala Khamesa-Israelov, et al.
Published: (2024-10-01)

The Effect and Treatment of PIK3CA Mutations in Breast Cancer: Current Understanding and Future Directions
by: Young-Bin Cho, et al.
Published: (2025-03-01)

Concurrent PIK3CA and IDH1 variants in facial infiltrating lipomatosis with intracranial lesions
by: Hongrui Chen, et al.
Published: (2025-03-01)

Characterizing multi‐PIK3CA mutations across cancer types: Toward precision oncology
by: Kohei Nakamura, et al.
Published: (2024-07-01)

Penfluridol targets septin7 to suppress endometrial cancer by septin7-Orai/IP3R-Ca2+-PIK3CA pathway
by: Lingyi Song, et al.
Published: (2025-01-01)

Lack of phosphatidylinositol 3-kinase VPS34 in regulatory T cells leads to a fatal lymphoproliferative disorder without affecting their development
by: Christina J. F. Courreges, et al.
Published: (2024-11-01)

Case Report of Fibro-Adipose Vascular Anomaly (FAVA) with Activating Somatic PIK3CA Mutation
by: Jordan H. Driskill, et al.
Published: (2022-01-01)

Ubiquitous expression of an activating mutation in the Pik3ca gene reprograms glucose and lipid metabolism in mice.
by: Sabrina Caiazzo, et al.
Published: (2025-01-01)

Embryological cellular origins and hypoxia-mediated mechanisms in PIK3CA-driven refractory vascular malformations
by: Sota Torii, et al.
Published: (2025-04-01)

Inhibition of protein kinase D and its substrate phosphatidylinositol-4 kinase III beta blocks common human coronavirus replication
by: Huijuan Han, et al.
Published: (2024-12-01)

Amodiaquine drug pressure selects nonsynonymous mutations in pantothenate kinase 1, diacylglycerol kinase, and phosphatidylinositol-4 kinase in Plasmodium berghei ANKA [version 3; peer review: 1 approved, 3 approved with reservations, 1 not approved]
by: Peter Mwitari, et al.
Published: (2023-10-01)

p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors.
by: Wen-Liang Kuo, et al.
Published: (2014-01-01)

Ste12/Fab1 phosphatidylinositol-3-phosphate 5-kinase is required for nitrogen-regulated mitotic commitment and cell size control.
by: David Cobley, et al.
Published: (2017-01-01)

A phosphatidylinositol-3-kinase-dependent signal transition regulates ARF1 and ARF6 during Fcgamma receptor-mediated phagocytosis.
by: Peter Beemiller, et al.
Published: (2006-06-01)

Comprehensive analysis of PIK3CA mutations in advanced colorectal cancer using circulating tumor DNA profiling
by: Allante Milsap, et al.
Published: (2025-07-01)

METTL3/IGF2BP2 Promotes the Malignant Progression of Esophageal Cancer by Activating the PIK3CA/AKT Pathway
by: Xinmeng Guo, et al.
Published: (2025-02-01)

LINC01271 promotes fracture healing via regulating miR-19a-3p/PIK3CA axis
by: Qinghua Chen, et al.
Published: (2025-01-01)

The human adenovirus E4-ORF1 protein subverts discs large 1 to mediate membrane recruitment and dysregulation of phosphatidylinositol 3-kinase.
by: Kathleen Kong, et al.
Published: (2014-05-01)